During the past decade, Parexel International conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Parexel International" #1 sponsor was "Astellas Pharma Global Development, Inc." with 10 trials, followed by "Bristol-Myers Squibb" with 9 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 6 trials sponsored, "9 Meters Biopharma, Inc." with 2 trials sponsored and "Alexion" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Parexel International" #1 collaborator was "Basilea Pharmaceutica International Ltd" with 2 trials as a collaborator, "Kyowa Kirin Co., Ltd." with 2 trials as a collaborator, "Glaxo Wellcome" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Parexel International" are "HIV Infections" (6 trials), "Healthy" (6 trials), "Chronic Hepatitis C" (5 trials), "Healthy Subjects" (5 trials) and "Healthy Volunteers" (5 trials). Many other conditions were trialed in "Parexel International" in a lesser frequency.

Most popular intervention types in "Parexel International" are "Drug" (39 trials), "Other" (3 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "ALXN1007" (2 trials), "ASP2408" (2 trials), "BMS-708163" (2 trials) and "Daclatasvir" (2 trials). Other intervention names were less common.

The vast majority of trials in "Parexel International" are 40 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Parexel International". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in Parexel International, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Parexel International, 33 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".